SEC Form 4 · accession 0001567619-18-003282
Spyre Therapeutics, Inc. · SYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aaron Schuchart
Officer — Chief Business Officer
Period of report
Sep 27, 2018
Accepted (ET)
Sep 28, 2018 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636282
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 27, 2018 | S | 100 | $9.55 | D | 8,400 | D | |
| Common Stock | Sep 27, 2018 | S | 5,900 | $9.50 | D | 2,500 | D |
Table II — derivative securities
No Table II lines on this filing.